Featured
Published on May 1st, 2022 📆 | 5339 Views ⚑
0ViaLase technology could impact glaucoma care for patients worldwide
OPT-302 combination therapy with ranibizumab shows BCVA, anatomic improvements in patients with PCV
Riad Sherif, CEO of Oculis, gives a company update on clinical trials, financing and other items in the pipeline
Study: Surgeon and anesthesiologist satisfaction an unreliable indicator of patient satisfaction during ocular surgery
Gloss